Carasent AB (publ) (FRA:E0C) Common Stock: €0.05 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:E0C Carasent AB (publ) FRA:E0C
79 GF Score
Price €2.06
GF Value €2.46
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Carasent AB (publ) Common Stock?

Carasent AB (publ) FRA:E0C +2.24% 79 Common Stock is €0.05 Mil as of Jun. 2026. GuruFocus rates FRA:E0C with a GF Score™ of 79/100 and a GF Value™ of €2.46 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Carasent AB (publ)'s quarterly common stock stayed the same from Dec. 2025 (€0.05 Mil) to Mar. 2026 (€0.05 Mil) but then increased from Mar. 2026 (€0.05 Mil) to Jun. 2026 (€0.05 Mil).

Carasent AB (publ)'s annual common stock declined from Dec. 2023 (€8.50 Mil) to Dec. 2024 (€0.04 Mil) but then increased from Dec. 2024 (€0.04 Mil) to Dec. 2025 (€0.05 Mil).

Carasent AB (publ) Common Stock Historical Data

* Premium members only.

The historical data trend for Carasent AB (publ)'s Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carasent AB (publ) Common Stock Chart

Carasent AB (publ) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.46 10.21 8.50 0.04 0.05

Carasent AB (publ) Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.05 0.05 0.05 0.05
FRA:E0C
79GF Score
Carasent AB (publ) FRA:E0C
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carasent AB (publ) Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.05 Mil mean?
Carasent AB (publ) (FRA:E0C) has a Common Stock of €0.05 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Carasent AB (publ) and its competitors.
Is Carasent AB (publ)'s Common Stock too high?
Carasent AB (publ)'s current Common Stock is €0.05 Mil. Overall, Carasent AB (publ) has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carasent AB (publ)'s Common Stock compare to VEEV and BTSG?
Carasent AB (publ)'s Common Stock of €0.05 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Healthcare Providers & Services company?
A good Common Stock depends on the Healthcare Providers & Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Carasent AB (publ) and its competitors. Carasent AB (publ)'s current Common Stock is €0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carasent AB (publ) stock overvalued right now?
Based on GuruFocus' analysis, Carasent AB (publ) (FRA:E0C) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.46, compared to a current price of €2.06 — trading 16.5% below its estimated fair value. The current Common Stock is €0.05 Mil. Carasent AB (publ)'s overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Carasent AB (publ) (FRA:E0C), the current Common Stock is €0.05 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carasent AB (publ) (FRA:E0C) Overvalued in 2026?

Based on GuruFocus' analysis, Carasent AB (publ) stock appears to be undervalued. The current stock price of €2.06 is trading 16.5% below its estimated GF Value™ of €2.46. GuruFocus considers Carasent AB (publ) to be Modestly Undervalued.

Key valuation signals for FRA:E0C:

  • Common Stock: €0.05 Mil
  • GF Value™: €2.46 vs. price of €2.06 (16.5% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the FRA:E0C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carasent AB (publ) Business Description

Other Exchanges CARA:Sweden
Address Nellickevagen 24C, Gothenburg, NOR, 412 63
Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.
79GF Score

Get the complete analysis for FRA:E0C

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.06
Price
€2.46
GF Value